Oil stocks fall as crude prices decline
U.S. oil stocks declined as crude prices fell, with the S&P 500 energy index down 1.9% after reports that additional Saudi crude cargoes were available through Oman.
U.S. oil stocks declined as crude prices fell, with the S&P 500 energy index down 1.9% after reports that additional Saudi crude cargoes were available through Oman.
J.B. Hunt Transport Services (NASDAQ:JBHT) shares fell 11% after the company warned that third-quarter profit could decline 5% to 10% sequentially due to higher transportation costs.
Grifols (NASDAQ:GRFS) signed a 10-year renewable power purchase agreement with Engie covering 40 GWh of electricity annually from 2027 through 2037 to increase renewable energy use across its Spanish operations
Sunshine Biopharma (NASDAQ:SBFM) advanced its lead coronavirus PLpro inhibitor into IND-enabling studies after preclinical testing showed antiviral activity against SARS-CoV-2 variants.
Diana Shipping (NYSE:DSX) secured a new time charter agreement for its Kamsarmax dry bulk vessel m/v Astarte at a gross rate of US$17,000 per day, expected to generate about US$5.81 million in gross revenue over the minimum charter period.
Sphere Entertainment (NYSE:SPHR) and Lyft (NASDAQ:LYFT) announced a multi-year marketing partnership that names Lyft the official rideshare partner of Sphere.
CoreWeave (NASDAQ:CRWV) announced the deployment of multi-rack NVIDIA Vera Rubin NVL72 clusters on CoreWeave Cloud, enabling large-scale AI workloads using hundreds of NVIDIA Rubin GPUs in a single cluster.
Corporación América Airports (NYSE:CAAP) reported a 0.9% year-over-year decline in total passenger traffic in August 2026, with international growth partially offsetting lower domestic volumes.
Twist Bioscience (NASDAQ:TWST) entered an agreement with Lilly TuneLab, an artificial intelligence and machine learning drug discovery platform created by Eli Lilly (NYSE:LLY), to provide antibody characterization data services.
Adagio Medical (NASDAQ:ADGM) announced the first patient treated in a clinical study evaluating its next-generation vCLAS Ultra Ultra-Low Temperature Ablation system for sustained monomorphic ventricular tachycardia.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy